Nikki Kean
Survey Finds 1 in 5 Pain Patients Have Trouble Getting Opioid Prescriptions
Nearly 20% of patients who sought opioid-based pain medication within the past five years experienced difficulty ...
APRIL 30, 2019
Gabapentin and Opioids a Potentially Deadly Combo
Patients taking prescription opioids and gabapentin concomitantly have a 49% greater risk for opioid-related death ...
JULY 7, 2018
Gene Silencing May Be Next Big Thing for Amyloidosis
Los Angeles—An innovative new treatment that uses a natural process of gene silencing (RNA interference ...
JULY 7, 2018
Opioid Addiction Not Just a Young Person’s Disease
As the opioid abuse crisis continues to claim 115 lives a day, one at-risk group that has been overlooked is the ...
MARCH 14, 2018
FDA Strengthens Warning on Combining Benzos and Opioids
The FDA expanded its warnings against using opioids and benzodiazepines concomitantly. This action is based on new ...
FEBRUARY 28, 2018
DOAC Therapy Reduces Incidence of Cancer-Related VTE
Atlanta—The factor Xa inhibitor edoxaban (Savaysa, Daiichi-Sankyo) reduced occurrences of cancer-associated ...
FEBRUARY 28, 2018
Benzo Scripts Fall Among Older Vets but Remain ‘Too High’
A new study shows efforts to discourage benzodiazepine use in those over age 65 are starting to work, but many ...
FEBRUARY 23, 2018
Older Patients With Epilepsy Have High Risk for PK Interactions
Up to one-third of older patients with epilepsy receive a combination of antiepileptic drugs and non-epilepsy ...
FEBRUARY 12, 2018
Heading Off Teen Addiction: Education Key
Orlando, Fla.—Pharmacists can play a critical role in the prevention of substance use disorders and related ...
JANUARY 28, 2018
What New BP Guidelines Mean for Clinical Pharmacy
The American College of Cardiology (ACC) and the American Heart Association (AHA) issued new guidelines lowering ...
JANUARY 28, 2018
ORBITA Questions PCI/Stenting for Angina
The recently published ORBITA trial has upended the common belief that percutaneous coronary intervention (PCI) ...
JANUARY 22, 2018
Safety Concerns Raised for 2 Novel Agents
The postmarketing safety record of two recently approved dru gs with novel mechanisms of action has raised ...
JANUARY 22, 2018
